Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL9307907 | 0.89 | — | — | |
| Iodide SCHEMBL9307975 | 0.86 | TP53 (0.49) | TP53 | |
| Iodide SCHEMBL9307023 | 0.86 | TP53 (0.42) | TP53 | |
| Iodide SCHEMBL9306281 | 0.80 | — | — | |
| Iodide SCHEMBL9305527 | 0.79 | THRA (0.42) | — | |
| SCHEMBL9307850 | 0.79 | LMNA (0.57) | TP53 | |
| SCHEMBL9305774 | 0.79 | NFKB1 (0.57) | MAPT | |
| Iodide SCHEMBL9309582 | 0.77 | LTB4R2 (0.46) | TP53 | |
| Iodide SCHEMBL9307763 | 0.77 | THRA (0.43) | — | |
| SCHEMBL9306473 | 0.76 | HPGD (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5328921-A | Antagonist of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1994-07-12 | — | — | US | disclosed |
| US-5208247-A | Antianaphylactic agents or septic shock | AMERICAN CYANAMID COMPANY (US) | 1993-05-04 | — | — | US | disclosed |
| EP-0530444-A1 | Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1993-03-10 | — | — | EP | disclosed |